NASDAQ: MLYS Mineralys Therapeutics, Inc. 8-K

Mineralys Therapeutics reports Q4 and full-year 2025 financial results

Filed March 12, 2026 · Period ending March 12, 2026 · ~1 min read

3 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade MLYS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 5, 2026 2:15 AM